• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Targeted Approaches for In Situ Gut Microbiome Manipulation.靶向肠道微生物组原位操作方法。
JPEN J Parenter Enteral Nutr. 2020 May;44(4):581-588. doi: 10.1002/jpen.1779. Epub 2020 Feb 6.
2
Dudrick Research Symposium: Expanding the boundaries of cancer care through nutrition support.达德里克研究研讨会:通过营养支持拓展癌症护理的边界。
JPEN J Parenter Enteral Nutr. 2021 Nov;45(8):1683-1689. doi: 10.1002/jpen.2275. Epub 2021 Nov 16.
3
Dudrick Research Symposium 2015-Lean Tissue and Protein in Health and Disease.2015年达德里克研究研讨会——健康与疾病中的瘦组织和蛋白质
JPEN J Parenter Enteral Nutr. 2017 Feb;41(2):226-237. doi: 10.1177/0148607115619599. Epub 2016 Jul 11.
4
Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?肠道微生物群的操纵真的可以转化为心血管疾病管理的干预策略吗?
Folia Microbiol (Praha). 2021 Dec;66(6):897-916. doi: 10.1007/s12223-021-00926-5. Epub 2021 Oct 26.
5
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.益生菌、益生元、合生元和后生元对靶向肠道微生物群的代谢性疾病的影响和作用机制:一种叙述性综述。
Nutrients. 2021 Sep 15;13(9):3211. doi: 10.3390/nu13093211.
6
The role of the microbiome for human health: from basic science to clinical applications.微生物组对人类健康的作用:从基础科学到临床应用。
Eur J Nutr. 2018 May;57(Suppl 1):1-14. doi: 10.1007/s00394-018-1703-4.
7
Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.靶向肾脏病中的肠道微生物群:肾脏营养与代谢的未来。
J Ren Nutr. 2023 Nov;33(6S):S30-S39. doi: 10.1053/j.jrn.2022.12.004. Epub 2023 Aug 25.
8
A Renal Clinician's Guide to the Gut Microbiota.肾脏科医生实用指南:肠道微生物群
J Ren Nutr. 2020 Sep;30(5):384-395. doi: 10.1053/j.jrn.2019.11.002. Epub 2020 Jan 9.
9
Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement.探索肠道微生物群:益生菌、益生元、合生元和后生元作为人类健康和疾病改善的关键因素。
Food Sci Biotechnol. 2024 Jun 27;33(9):2065-2080. doi: 10.1007/s10068-024-01620-1. eCollection 2024 Jul.
10
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.过度喂养肠道微生物组:对健康影响和治疗观点的范围综述。
World J Gastroenterol. 2021 Nov 7;27(41):7041-7064. doi: 10.3748/wjg.v27.i41.7041.

引用本文的文献

1
The Effects of Tocotrienol on Gut Microbiota: A Scoping Review.生育三烯酚对肠道微生物群的影响:一项范围综述
Life (Basel). 2023 Sep 7;13(9):1882. doi: 10.3390/life13091882.
2
Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders.肠疾病患儿全肠外营养对肠道微生物群的影响。
Nutrients. 2022 Nov 6;14(21):4691. doi: 10.3390/nu14214691.
3
Advances in the human skin microbiota and its roles in cutaneous diseases.人类皮肤微生物组及其在皮肤疾病中的作用的研究进展。
Microb Cell Fact. 2022 Aug 29;21(1):176. doi: 10.1186/s12934-022-01901-6.
4
The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses.利用 CRISPR/Cas9 技术研究人类感染性病毒
Front Cell Infect Microbiol. 2021 Aug 27;11:590989. doi: 10.3389/fcimb.2021.590989. eCollection 2021.
5
Measuring Dietary Botanical Diversity as a Proxy for Phytochemical Exposure.测量饮食植物多样性作为植物化学物质暴露的替代指标。
Nutrients. 2021 Apr 14;13(4):1295. doi: 10.3390/nu13041295.
6
The gut-liver axis as a target of liver disease management.肠-肝轴作为肝病管理的靶点。
Hepatobiliary Surg Nutr. 2021 Jan;10(1):100-102. doi: 10.21037/hbsn.2020.03.27.
7
Microbiota reprogramming for treatment of alcohol-related liver disease.肠道菌群重编程治疗酒精相关性肝病。
Transl Res. 2020 Dec;226:26-38. doi: 10.1016/j.trsl.2020.07.004. Epub 2020 Jul 17.

本文引用的文献

1
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.益生菌和益生元在肠道健康和疾病中的作用:从生物学到临床。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):605-616. doi: 10.1038/s41575-019-0173-3. Epub 2019 Jul 11.
2
Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans.人类摄入亚麻籽木脂素提取物后结肠黏膜和脱落细胞转录组特征分析及粪便微生物组的反应。
Am J Clin Nutr. 2019 Aug 1;110(2):377-390. doi: 10.1093/ajcn/nqy325.
3
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases.健康的肠道微生物群组成是怎样的?一个随年龄、环境、饮食和疾病变化的生态系统。
Microorganisms. 2019 Jan 10;7(1):14. doi: 10.3390/microorganisms7010014.
4
A Designer Synbiotic Attenuates Chronic-Binge Ethanol-Induced Gut-Liver Injury in Mice.一种设计共生菌可减轻小鼠慢性 binge 乙醇诱导的肠道-肝脏损伤。
Nutrients. 2019 Jan 5;11(1):97. doi: 10.3390/nu11010097.
5
Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.饮食调节的丁酸生成对肠道屏障功能和炎症的影响。
Nutrients. 2018 Oct 13;10(10):1499. doi: 10.3390/nu10101499.
6
Tributyrin Supplementation Protects Immune Responses and Vasculature and Reduces Oxidative Stress in the Proximal Colon of Mice Exposed to Chronic-Binge Ethanol Feeding.丁酸甘油酯补充剂可保护暴露于慢性 binge 乙醇喂养的小鼠近端结肠中的免疫反应和血管,并减少氧化应激。
J Immunol Res. 2018 Aug 19;2018:9671919. doi: 10.1155/2018/9671919. eCollection 2018.
7
A prebiotic intervention study in children with autism spectrum disorders (ASDs).自闭症谱系障碍(ASD)儿童的益生元干预研究。
Microbiome. 2018 Aug 2;6(1):133. doi: 10.1186/s40168-018-0523-3.
8
The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.肠道共生菌在增强肠道屏障功能和缓解炎症方面的潜力。
Nutrients. 2018 Jul 29;10(8):988. doi: 10.3390/nu10080988.
9
Gut microbiome and aging: Physiological and mechanistic insights.肠道微生物群与衰老:生理及机制见解
Nutr Healthy Aging. 2018 Jun 15;4(4):267-285. doi: 10.3233/NHA-170030.
10
The Gut Microbiome Profile in Obesity: A Systematic Review.肥胖中的肠道微生物群概况:一项系统综述。
Int J Endocrinol. 2018 Mar 22;2018:4095789. doi: 10.1155/2018/4095789. eCollection 2018.

靶向肠道微生物组原位操作方法。

Targeted Approaches for In Situ Gut Microbiome Manipulation.

机构信息

Department of Pediatric Gastroenterology, Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA.

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

JPEN J Parenter Enteral Nutr. 2020 May;44(4):581-588. doi: 10.1002/jpen.1779. Epub 2020 Feb 6.

DOI:10.1002/jpen.1779
PMID:32027044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9291485/
Abstract

The 2019 Dudrick Research Symposium, entitled "Targeted Approaches for In Situ Gut Microbiome Manipulation," was held on March 25, 2019, at the American Society for Parenteral and Enteral Nutrition (ASPEN) 2019 Nutrition Science & Practice Conference in Phoenix, AZ. The Dudrick Symposium honors the many pivotal and innovative contributions to the development and advancement of parenteral nutrition (PN) made by Dr Stanley J. Dudrick, physician scientist, academic leader, and a founding member of ASPEN. As the 2018 recipient of the Dudrick award, Dr Gail Cresci organized and chaired the symposium. The symposium addressed the evolving field of nutrition manipulation of the gut microbiome as a means to mitigate disease and support health. Presentations focused on (1) the role of prebiotics as a means to beneficially support gut microbiome composition and function and health; (2) designer synbiotics targeted to support metabolic by-products altered by ethanol exposure and microbial effectors that manipulate host metabolic outcomes; and, lastly, (3) types of intervention designs used to study diet-gut microbiome interactions in humans and a review of findings from recent interventions, which tested the effects of diet on the microbiome and the microbiome's effect on dietary exposures. New molecular techniques and multiomic approaches have improved knowledge of the structure and functional activity of the gut microbiome; however, challenges remain in establishing causal relationships between changes in the gut microbial-community structure and function and health outcomes in humans.

摘要

2019 年杜德里克研究研讨会的主题是“原位肠道微生物群操作的靶向方法”,于 2019 年 3 月 25 日在美国肠外和肠内营养学会 (ASPEN) 2019 年营养科学与实践会议在亚利桑那州凤凰城举行。杜德里克研讨会旨在纪念斯坦利·J·杜德里克博士 (Stanley J. Dudrick, MD) 在肠外营养 (PN) 发展和进步方面所做出的许多重要而具有创新性的贡献。他既是一位医师科学家,也是学术领袖,同时也是 ASPEN 的创始成员之一。作为 2018 年杜德里克奖的获得者,盖尔·克雷斯西博士 (Gail Cresci, MD) 组织并主持了研讨会。该研讨会探讨了营养操纵肠道微生物群作为减轻疾病和支持健康的一种手段的不断发展的领域。演讲重点介绍了:(1) 作为有益地支持肠道微生物群组成、功能和健康的手段,益生菌的作用;(2) 靶向设计的共生体,以支持因乙醇暴露而改变的代谢产物和操纵宿主代谢结果的微生物效应物;最后,(3)用于研究人类饮食-肠道微生物群相互作用的干预设计类型,以及对最近干预措施的发现进行综述,这些干预措施测试了饮食对微生物组的影响以及微生物组对饮食暴露的影响。新的分子技术和多组学方法提高了对肠道微生物群结构和功能活性的认识;然而,在确定肠道微生物群落结构和功能变化与人类健康结果之间的因果关系方面仍然存在挑战。